In an infant with weeping papules and scaling on the scalp, what is the most likely diagnosis and recommended treatment?

Weeping Papules and Scaling on Infant Scalp: Diagnosis and Treatment

The most likely diagnosis is tinea capitis (scalp ringworm), and you should initiate oral griseofulvin at 15-20 mg/kg/day for 6-8 weeks while awaiting fungal culture confirmation. 1

Clinical Recognition

In an infant presenting with weeping papules and scaling on the scalp, you're likely seeing one of two tinea capitis patterns:

• Kerion: A painful, boggy, inflammatory mass with pustules, crusting, and associated alopecia—this represents a delayed inflammatory host response to dermatophyte infection 1
• Diffuse pustular variant: Patchy alopecia with scattered pustules or low-grade folliculitis, often with regional lymphadenopathy 1

The "weeping" nature strongly suggests an inflammatory variant rather than simple seborrheic dermatitis, which would present with greasy yellow scales without pustulation.

Immediate Diagnostic Steps

Obtain fungal specimens before starting treatment, but don't delay therapy if clinical features are convincing 1. The presence of scaling, lymphadenopathy, or alopecia are strong predictive factors that justify immediate treatment while awaiting culture results (which take 2-4 weeks) 1.

Sample the scalp using:

• Scalpel scraping of scale and hair
• Hair plucking from affected areas
• Brush or swab technique 1

Send for both microscopy and culture—culture is essential to identify the specific dermatophyte and guide ongoing therapy 1.

Treatment Algorithm

First-Line Systemic Therapy

Oral griseofulvin remains the only licensed treatment for tinea capitis in children in the UK and should be your first choice 1:

Dosing for infants:

• 15-20 mg/kg/day (single or divided dose) for 6-8 weeks 1
• Give with fatty food to enhance absorption 1

Critical point: Topical therapy alone is NOT adequate—oral therapy is required to penetrate the hair shaft and achieve mycological cure 1. However, add topical antifungal shampoo (ketoconazole 2% or selenium sulfide 1%) to reduce spore transmission 1.

Species-Specific Considerations

Once culture results return, adjust therapy if needed:

• Microsporum species (M. canis): Continue griseofulvin—it's more effective than terbinafine for Microsporum 1
• Trichophyton species (T. tonsurans, T. violaceum): Griseofulvin works but may require higher doses (up to 25 mg/kg/day) for 12-18 weeks, or consider switching to terbinafine 1

In the UK, T. tonsurans accounts for 50-90% of cases, but M. canis remains common in Europe 1. Recent data shows M. canis is the leading pathogen in infants under 2 years (50.79% of cases) 2.

Managing Inflammatory Disease (Kerion)

If you're seeing a kerion with significant inflammation:

• Do NOT mistake this for bacterial abscess—it's a host inflammatory response to fungus, not bacterial infection 1
• Start oral griseofulvin immediately
• Consider adding oral corticosteroids for severe inflammation (though evidence is limited)
• Watch for secondary bacterial infection, which can occur

Common Pitfalls to Avoid

1. Don't use topical antifungals alone—they cannot penetrate the hair shaft adequately 1
2. Don't assume it's seborrheic dermatitis—weeping and pustulation point to tinea capitis, especially with any alopecia 3, 4
3. Don't wait for culture before treating if clinical signs are strong—delays increase scarring risk and transmission 1
4. Don't underdose or undertreat—inadequate duration leads to treatment failure and recurrence 1

Monitoring and Follow-Up

• Reassess at 2-4 weeks for clinical improvement
• If improving but mycology still positive: continue therapy for additional 2-4 weeks 1
• If no clinical improvement: consider compliance issues, drug absorption problems, or switch to second-line therapy (itraconazole) 1
• Obtain post-treatment cultures to confirm mycological cure 4

Special Considerations for Infants

While tinea capitis is rare in neonates and young infants 5, 2, when it occurs:

• M. canis is the most common pathogen (often from animal contact) 2
• Griseofulvin has been used successfully with good safety profile 2
• Some case reports show topical therapy success in neonates 5, but this is NOT standard practice and should only be considered in exceptional circumstances with close monitoring

The key to preventing permanent scarring alopecia is early recognition and prompt systemic antifungal therapy 3, 4.